InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,584.54
(
-0.88%
)
US TECH 100
19,659.60
(
-2.28%
)
Dow Jones
39,753.75
(
0.08%
)
Brent Oil
85.37
(
0.31%
)
Bitcoin
57,277.03
(
-0.13%
)
Post# of 14688
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

docj

Send PM Follow Ignore
Followers 22
Posts 2468
Boards Moderated 2
Alias Born 09/15/2011

docj

Re: None

Thursday, 04/30/2020 6:59:51 PM

Thursday, April 30, 2020 6:59:51 PM

Post# of 14688
Our vaccine vs the rest:

We are highly specific Th1 T cell and B cell activation toward portions of SARS-CoV-2 proteins for which their is very good evidence of protection. No one else has this. Everyone else is doing sub unit vaccines, for which there is very good evidence that portions of those sub units trigger disease enhancement.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up